T212. LEVELS OF GLUTAMATERGIC NEUROMETABOLITES IN PATIENTS WITH SEVERE TREATMENT-RESISTANT SCHIZOPHRENIA: A PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDY

BACKGROUND: Approximately 30% of patients with schizophrenia do not respond to antipsychotics and are thus considered to have treatment-resistant schizophrenia (TRS). To date, only four studies have examined glutamatergic neurometabolite levels using proton magnetic resonance spectroscopy (1H-MRS) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarumi, Ryosuke, Tsugawa, Sakiko, Noda, Yoshihiro, Plitman, Eric, Honda, Shiori, Matshusita, Karin, Chavez, Sofia, Sawada, Kyosuke, Wada, Masataka, Matsui, Mie, Fujii, Shinya, Miyazaki, Takahiro, Chakravarty, Mallar, Uchida, Hiroyuki, Remington, Gary, Graff-Guerrero, Ariel, Mimura, Masaru, Nakajima, Shinichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Session III
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234367/
http://dx.doi.org/10.1093/schbul/sbaa029.772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234367/
http://dx.doi.org/10.1093/schbul/sbaa029.772

Ejemplares similares